Stock listing
Ensysce Biosciences, Inc.
Selected listing: ENSC · NASDAQ · USD · US
Ensysce Biosciences, Inc. (NASDAQ:ENSC), Health Technology. Latest release Sep 15, 2026: Ensysce Biosciences Advances CRPS Program at Painweek 2026…
- Ticker
- NASDAQ:ENSC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. is a public company traded under the ticker ENSC in the American market. Ensysce focuses on developing innovative solutions in the biosciences sector.
Latest news from Ensysce Biosciences, Inc.
Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation
September 15, 2026
Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
September 14, 2026
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
September 2, 2026
Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
August 31, 2026
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 13, 2026
Events
Research Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. company profile
View the public company page for Ensysce Biosciences, Inc. on 6ix.
Ensysce Biosciences, Inc. news
Read company news and market updates connected to Ensysce Biosciences, Inc..
Ensysce Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Ensysce Biosciences, Inc..